ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01365533
Recruitment Status : Completed
First Posted : June 3, 2011
Last Update Posted : October 25, 2016
Sponsor:
Information provided by (Responsible Party):
AstraZeneca